Compare Abeona Therapeutics Inc (ABEO) vs Invesco Galaxy Bitcoin ETF (BTCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Invesco Galaxy Bitcoin ETF — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Invesco Galaxy Bitcoin ETF trades at $63.04. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, Invesco Galaxy Bitcoin ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | BTCO | |
|---|---|---|
Market Cap | $421.19M | — |
Sector | Health | Crypto-linked |
52-Week High | $7.45 | $125.14 |
52-Week Low | $4.17 | $58.40 |
Enterprise Value | $276.10M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $7.24, up 4.93% today, with bullish technical signals from moving averages. The company shows exceptional profitability with 454.86% net income margin and 70.99% ROE, though revenue remains modest at $5.82M. Recent developments include CMS granting NTAP status for ZEVASKYN and expansion to seven treatment centers, while Q2 2026 earnings are scheduled for August 13, 2026.
Strong analyst support (66.7% buy ratings) and attractive valuation metrics (P/E 7.84, EV/EBITDA 3.8) support upside potential, but negative operating cash flow and shareholder investigation pose near-term risks. The stock's outlook depends on commercial execution and Q2 earnings results.
BTCO stock trades at $64.60, up 0.86% today amid mixed technical signals. The overall technical picture shows bearish momentum with key support at $63 and resistance at $65. Financial ratios remain unavailable in current data, requiring fundamental verification through SEC filings.
Investment outlook hinges on forthcoming financial disclosures to assess valuation. Key risks include market volatility and competitive pressures. The stock's near-term direction will likely be driven by earnings results and institutional positioning updates.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Invesco Galaxy Bitcoin ETF
BTCO is a spot Bitcoin ETF that tracks the price of Bitcoin directly. It offers investors a regulated and convenient way to gain exposure to the digital currency through a traditional brokerage account without holding the asset.
Read more on BTCO →
